Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
VistaGen Staggered By Latest Clinical Setback, This Time In Social Anxiety
Jul 22 2022
•
By
Joseph Haas
VistaGen tested its SAD candidate in a public speaking model • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Clinical Trials
More from R&D